Pectasides, D., Karavasilis, V., Papaxoinis, G., Gourgioti, G., Makatsoris, T., Raptou, G., . . . Fountzilas, G. (2015). Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer. BMC Cancer.
Citación estilo ChicagoPectasides, Dimitrios, et al. "Randomized Phase III Clinical Trial Comparing the Combination of Capecitabine and Oxaliplatin (CAPOX) With the Combination of 5-fluorouracil, Leucovorin and Oxaliplatin (modified FOLFOX6) As Adjuvant Therapy in Patients With Operated High-risk Stage II or Stage III Colorectal Cancer." BMC Cancer 2015.
Cita MLAPectasides, Dimitrios, et al. "Randomized Phase III Clinical Trial Comparing the Combination of Capecitabine and Oxaliplatin (CAPOX) With the Combination of 5-fluorouracil, Leucovorin and Oxaliplatin (modified FOLFOX6) As Adjuvant Therapy in Patients With Operated High-risk Stage II or Stage III Colorectal Cancer." BMC Cancer 2015.